A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday will vote on the use of Pfizer's respiratory syncytial virus (RSV) vaccine in pregnant women, likely paving the way for it to become the country's first maternal shot for protecting babies from the virus.

The US Centers for Disease Control and Prevention said Friday it is recommending a new vaccine to help protect babies against severe respiratory syncytial virus, or RSV. “This is another new tool we can use this fall and winter to help protect lives,